Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Barrett

Showing results (311-320 of 349) with videos related to

Pageof 35
Sort By:
British Journal of Haematology|June 21, 2019
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapyMichael D Keller, Sam Darko, Haili Lang, et al.
Journal of Immunological Methods|August 5, 2008
Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramersJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Military Medicine|September 23, 2025
The Veteran Military Occupational and Environmental Exposure Assessment Tool, Phase III EnhancementsCalvin Lu, Patricia Stewart, Charity Breneman, et al.
Blood|October 22, 2005
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantationHanna J Khoury, Fausto R Loberiza, Olle Ringdén, et al.
Blood|June 5, 2008
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse populationSumithira Vasu, Susan F Leitman, John F Tisdale, et al.
Bone Marrow Transplantation|November 12, 2014
Clinical and biological predictors of outcome following relapse of CML post-allo-SCTNatasha A Jain, Sawa Ito, Xin Tian, et al.
Blood|July 2, 2002
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseStephanie J Lee, John P Klein, A John Barrett, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2012
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trialKatherine K Matthay, Brian Weiss, Judith G Villablanca, et al.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Pageof 35

Showing results (311-320 of 349) with videos related to

Sort By:
Pageof 35
British Journal of Haematology|June 21, 2019
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapyMichael D Keller, Sam Darko, Haili Lang, et al.
Journal of Immunological Methods|August 5, 2008
Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramersJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Military Medicine|September 23, 2025
The Veteran Military Occupational and Environmental Exposure Assessment Tool, Phase III EnhancementsCalvin Lu, Patricia Stewart, Charity Breneman, et al.
Blood|October 22, 2005
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantationHanna J Khoury, Fausto R Loberiza, Olle Ringdén, et al.
Blood|June 5, 2008
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse populationSumithira Vasu, Susan F Leitman, John F Tisdale, et al.
Bone Marrow Transplantation|November 12, 2014
Clinical and biological predictors of outcome following relapse of CML post-allo-SCTNatasha A Jain, Sawa Ito, Xin Tian, et al.
Blood|July 2, 2002
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseStephanie J Lee, John P Klein, A John Barrett, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2012
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trialKatherine K Matthay, Brian Weiss, Judith G Villablanca, et al.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Pageof 35